'We are fully supportive of Pfizer Chairman and CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver...
- Pfizer 's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value , which wants the U.S. drug giant to make changes to turn its performance around.
"We are fully supportive of Pfizer Chairman and CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value," the executives said in a statement on Wednesday, which was issued by Guggenheim Partners, an advisor to Pfizer.
China's National Bureau of Statistics said it will conduct a nationwide sample survey from Thursday to "accurately" monitor population changes and better plan economic and social policies, as authorities struggle to boost a fall in births. Beijing is urgently trying a variety of measures to incentivise young couples to have children after China posted a second consecutive year of population decline in 2023.
BRANTFORD, Ont. — Nick Lardis scored a hat trick for the Brantford Bulldogs in a 5-1 win over the Sarnia Sting on Wednesday in the Ontario Hockey League.The stakes for the September CPI report are higher after last week's red-hot jobs data. An upside surprise could stoke fresh volatility for stocks.The immigrant services non-profit S.U.C.C.E.S.S. says that its co-founder Maggie Ip has died more than 50 years after she began the agency to help newcomers to Canada.
Pfizer Frank D'amelio Albert Bourla Activist Investor Ian Read Guggenheim Partners
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reportsActivist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. drug giant to make changes to turn its performance around...
Read more »
Pfizer CEO plans to meet activist investor Starboard Value, FT reportsPfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter...
Read more »
Activist Investor Starboard Takes $1 Billion Stake in Pfizer Seeking TurnaroundStarboard Value, an activist investor, has acquired a significant stake in Pfizer and aims to revitalize the pharmaceutical giant. The firm has reached out to former Pfizer executives Ian Read and Frank D'Amelio for assistance, who have expressed interest in contributing to the turnaround efforts.
Read more »
Starboard reportedly targets Pfizer, markets waver amid uncertainty: Yahoo FinancePfizer (PFE) shares are higher this morning following a Wall Street Journal report that activist investment firm Starboard Value has taken a $1 billion stake...
Read more »
Ratan Tata, the former chairman of Indian conglomerate Tata Sons, dies at 86NEW DELHI (AP) — Ratan Tata, a former chairman of Indian conglomerate Tata Sons hailed as a visionary business leader, died at a Mumbai hospital on Wednesday night. He was 86.
Read more »
Ratan Tata, former chairman of Tata Group, dies at age 86Ratan Tata, a former chairman of India’s oldest conglomerate Tata Sons, died at a Mumbai hospital on Wednesday night. He was 86.
Read more »